nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—chronic obstructive pulmonary disease	0.207	0.514	CiPCiCtD
Amcinonide—Corticosteroid Hormone Receptor Agonists—Prednisone—chronic obstructive pulmonary disease	0.196	0.486	CiPCiCtD
Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.146	0.506	CrCtD
Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.143	0.494	CrCtD
Amcinonide—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0406	0.514	CbGbCtD
Amcinonide—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0383	0.486	CbGbCtD
Amcinonide—Ciclesonide—Prednisone—chronic obstructive pulmonary disease	0.00671	0.0339	CrCrCtD
Amcinonide—Ciclesonide—Prednisolone—chronic obstructive pulmonary disease	0.00655	0.0331	CrCrCtD
Amcinonide—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.00586	0.0296	CrCrCtD
Amcinonide—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.00544	0.0275	CrCrCtD
Amcinonide—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.00531	0.0269	CrCrCtD
Amcinonide—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.00528	0.0267	CrCrCtD
Amcinonide—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00515	0.0261	CrCrCtD
Amcinonide—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00515	0.0261	CrCrCtD
Amcinonide—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00487	0.0246	CrCrCtD
Amcinonide—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00485	0.0245	CrCrCtD
Amcinonide—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.00474	0.024	CrCrCtD
Amcinonide—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.00474	0.024	CrCrCtD
Amcinonide—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00473	0.0239	CrCrCtD
Amcinonide—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00473	0.0239	CrCrCtD
Amcinonide—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00473	0.0239	CrCrCtD
Amcinonide—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00473	0.0239	CrCrCtD
Amcinonide—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00473	0.0239	CrCrCtD
Amcinonide—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00461	0.0233	CrCrCtD
Amcinonide—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00461	0.0233	CrCrCtD
Amcinonide—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00461	0.0233	CrCrCtD
Amcinonide—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00461	0.0233	CrCrCtD
Amcinonide—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.00461	0.0233	CrCrCtD
Amcinonide—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00461	0.0233	CrCrCtD
Amcinonide—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.0045	0.0227	CrCrCtD
Amcinonide—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00439	0.0222	CrCrCtD
Amcinonide—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.00439	0.0222	CrCrCtD
Amcinonide—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00439	0.0222	CrCrCtD
Amcinonide—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00439	0.0222	CrCrCtD
Amcinonide—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00439	0.0222	CrCrCtD
Amcinonide—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00439	0.0222	CrCrCtD
Amcinonide—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00429	0.0217	CrCrCtD
Amcinonide—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00429	0.0217	CrCrCtD
Amcinonide—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00429	0.0217	CrCrCtD
Amcinonide—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00429	0.0217	CrCrCtD
Amcinonide—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00429	0.0217	CrCrCtD
Amcinonide—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00429	0.0217	CrCrCtD
Amcinonide—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00429	0.0217	CrCrCtD
Amcinonide—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00429	0.0217	CrCrCtD
Amcinonide—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00419	0.0212	CrCrCtD
Amcinonide—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00419	0.0212	CrCrCtD
Amcinonide—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00419	0.0212	CrCrCtD
Amcinonide—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00402	0.0203	CrCrCtD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.0023	0.207	CbGpPWpGaD
Amcinonide—ANXA1—respiratory system—chronic obstructive pulmonary disease	0.00106	0.155	CbGeAlD
Amcinonide—ANXA1—connective tissue—chronic obstructive pulmonary disease	0.000932	0.137	CbGeAlD
Amcinonide—ANXA1—bronchus—chronic obstructive pulmonary disease	0.000871	0.128	CbGeAlD
Amcinonide—Secondary adrenocortical insufficiency—Prednisone—chronic obstructive pulmonary disease	0.000861	0.069	CcSEcCtD
Amcinonide—ANXA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000852	0.125	CbGeAlD
Amcinonide—Cataract subcapsular—Prednisolone—chronic obstructive pulmonary disease	0.000788	0.0631	CcSEcCtD
Amcinonide—ANXA1—trachea—chronic obstructive pulmonary disease	0.000782	0.115	CbGeAlD
Amcinonide—Skin striae—Prednisolone—chronic obstructive pulmonary disease	0.000647	0.0518	CcSEcCtD
Amcinonide—Telangiectasia—Prednisone—chronic obstructive pulmonary disease	0.000634	0.0508	CcSEcCtD
Amcinonide—Atrophy—Prednisolone—chronic obstructive pulmonary disease	0.000631	0.0506	CcSEcCtD
Amcinonide—Acneiform eruption—Prednisone—chronic obstructive pulmonary disease	0.000591	0.0474	CcSEcCtD
Amcinonide—Cataract subcapsular—Prednisone—chronic obstructive pulmonary disease	0.000572	0.0459	CcSEcCtD
Amcinonide—ANXA1—lung—chronic obstructive pulmonary disease	0.000562	0.0825	CbGeAlD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000561	0.0504	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000548	0.0492	CbGpPWpGaD
Amcinonide—Skin atrophy—Prednisone—chronic obstructive pulmonary disease	0.000495	0.0397	CcSEcCtD
Amcinonide—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.000493	0.0395	CcSEcCtD
Amcinonide—Leukoderma—Prednisolone—chronic obstructive pulmonary disease	0.000484	0.0388	CcSEcCtD
Amcinonide—Skin striae—Prednisone—chronic obstructive pulmonary disease	0.00047	0.0377	CcSEcCtD
Amcinonide—Atrophy—Prednisone—chronic obstructive pulmonary disease	0.000458	0.0367	CcSEcCtD
Amcinonide—Dermatitis acneiform—Prednisone—chronic obstructive pulmonary disease	0.000437	0.0351	CcSEcCtD
Amcinonide—Hypertrichosis—Prednisone—chronic obstructive pulmonary disease	0.000393	0.0315	CcSEcCtD
Amcinonide—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.0301	CcSEcCtD
Amcinonide—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.000375	0.0301	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000373	0.0335	CbGpPWpGaD
Amcinonide—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000368	0.054	CbGeAlD
Amcinonide—Leukoderma—Prednisone—chronic obstructive pulmonary disease	0.000351	0.0282	CcSEcCtD
Amcinonide—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000324	0.0475	CbGeAlD
Amcinonide—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000303	0.0444	CbGeAlD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000298	0.0267	CbGpPWpGaD
Amcinonide—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000296	0.0434	CbGeAlD
Amcinonide—NR3C1—trachea—chronic obstructive pulmonary disease	0.000272	0.0399	CbGeAlD
Amcinonide—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000265	0.0213	CcSEcCtD
Amcinonide—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.0203	CcSEcCtD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000229	0.0205	CbGpPWpGaD
Amcinonide—NR3C1—lung—chronic obstructive pulmonary disease	0.000195	0.0286	CbGeAlD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000193	0.0173	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	0.000185	0.0166	CbGpPWpGaD
Amcinonide—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.0142	CcSEcCtD
Amcinonide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000168	0.0135	CcSEcCtD
Amcinonide—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.0134	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000153	0.0138	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000153	0.0137	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000149	0.0134	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000142	0.0128	CbGpPWpGaD
Amcinonide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000135	0.0108	CcSEcCtD
Amcinonide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.0108	CcSEcCtD
Amcinonide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000132	0.0106	CcSEcCtD
Amcinonide—ANXA1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00013	0.0117	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000129	0.0116	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000128	0.0115	CbGpPWpGaD
Amcinonide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.0102	CcSEcCtD
Amcinonide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.0101	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	0.000125	0.0113	CbGpPWpGaD
Amcinonide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.00952	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000117	0.0105	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000116	0.0104	CbGpPWpGaD
Amcinonide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00928	CcSEcCtD
Amcinonide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00928	CcSEcCtD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000114	0.0102	CbGpPWpGaD
Amcinonide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00909	CcSEcCtD
Amcinonide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.00899	CcSEcCtD
Amcinonide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00877	CcSEcCtD
Amcinonide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000106	0.00847	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000105	0.00939	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	0.000103	0.0093	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000102	0.00912	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000101	0.00911	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	9.73e-05	0.00874	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	9.62e-05	0.00864	CbGpPWpGaD
Amcinonide—Pruritus—Formoterol—chronic obstructive pulmonary disease	9.58e-05	0.00768	CcSEcCtD
Amcinonide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	9.58e-05	0.00768	CcSEcCtD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	9.57e-05	0.0086	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	9.57e-05	0.00859	CbGpPWpGaD
Amcinonide—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	9.44e-05	0.282	CrCbGaD
Amcinonide—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.39e-05	0.00752	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	9.17e-05	0.00824	CbGpPWpGaD
Amcinonide—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	9.1e-05	0.272	CrCbGaD
Amcinonide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	9.05e-05	0.00725	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	9e-05	0.00809	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	8.9e-05	0.008	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.6e-05	0.00772	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	8.55e-05	0.00768	CbGpPWpGaD
Amcinonide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.53e-05	0.00684	CcSEcCtD
Amcinonide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.53e-05	0.00684	CcSEcCtD
Amcinonide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.36e-05	0.0067	CcSEcCtD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	8.32e-05	0.00747	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.19e-05	0.00735	CbGpPWpGaD
Amcinonide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.06e-05	0.00646	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	7.92e-05	0.00711	CbGpPWpGaD
Amcinonide—Dexamethasone—NOS2—chronic obstructive pulmonary disease	7.69e-05	0.23	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	7.57e-05	0.0068	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	7.56e-05	0.00679	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.52e-05	0.00676	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	7.49e-05	0.00673	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.44e-05	0.00668	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	7.43e-05	0.00667	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	7.41e-05	0.00666	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.33e-05	0.00658	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	7.18e-05	0.00645	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	7.06e-05	0.00634	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	6.97e-05	0.00626	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	6.93e-05	0.00622	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	6.9e-05	0.0062	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	6.76e-05	0.00608	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.76e-05	0.00607	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	6.67e-05	0.00599	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.6e-05	0.00593	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.55e-05	0.00588	CbGpPWpGaD
Amcinonide—Pain—Prednisolone—chronic obstructive pulmonary disease	6.27e-05	0.00503	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	6.22e-05	0.00559	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.08e-05	0.00547	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.99e-05	0.00538	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	5.84e-05	0.00525	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.8e-05	0.00521	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.73e-05	0.00514	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	5.7e-05	0.00512	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.6e-05	0.00503	CbGpPWpGaD
Amcinonide—Infection—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.00424	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.14e-05	0.00462	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	5.11e-05	0.00459	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.11e-05	0.00459	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.04e-05	0.00453	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	4.87e-05	0.00437	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.8e-05	0.00431	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	4.69e-05	0.00421	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.65e-05	0.00417	CbGpPWpGaD
Amcinonide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.62e-05	0.0037	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.59e-05	0.00412	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	4.46e-05	0.00401	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	4.4e-05	0.00395	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.39e-05	0.00395	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	4.29e-05	0.00385	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.23e-05	0.0038	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	4.15e-05	0.00373	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.14e-05	0.00372	CbGpPWpGaD
Amcinonide—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.00302	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.76e-05	0.00338	CbGpPWpGaD
Amcinonide—Prednisone—ALB—chronic obstructive pulmonary disease	3.74e-05	0.112	CrCbGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	3.71e-05	0.00334	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.7e-05	0.00332	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	3.63e-05	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.54e-05	0.00318	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.54e-05	0.00318	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.105	CrCbGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.52e-05	0.00317	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	3.5e-05	0.00315	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.36e-05	0.00302	CbGpPWpGaD
Amcinonide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.36e-05	0.00269	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.24e-05	0.00291	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	2.99e-05	0.00268	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.94e-05	0.00264	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	2.8e-05	0.00252	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	2.73e-05	0.00246	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	2.63e-05	0.00236	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.59e-05	0.00233	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.56e-05	0.0023	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.46e-05	0.00221	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	2.41e-05	0.00216	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.41e-05	0.00216	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.22e-05	0.002	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	2.21e-05	0.00199	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.08e-05	0.00187	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	2.06e-05	0.00185	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2e-05	0.0018	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.98e-05	0.00178	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.82e-05	0.00163	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.8e-05	0.00162	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.78e-05	0.0016	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.74e-05	0.00156	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	1.67e-05	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.61e-05	0.00145	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.44e-05	0.00129	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.35e-05	0.00121	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.33e-05	0.00119	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.28e-05	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.27e-05	0.00114	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.26e-05	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.21e-05	0.00109	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.000964	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.02e-05	0.000916	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.7e-06	0.000872	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.71e-06	0.000783	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8e-06	0.000718	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.84e-06	0.000704	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.58e-06	0.000591	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	6.16e-06	0.000553	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.03e-06	0.000541	CbGpPWpGaD
